HK1152470A1 - Peptides for treating beta amyloidoses - Google Patents

Peptides for treating beta amyloidoses

Info

Publication number
HK1152470A1
HK1152470A1 HK11106465.0A HK11106465A HK1152470A1 HK 1152470 A1 HK1152470 A1 HK 1152470A1 HK 11106465 A HK11106465 A HK 11106465A HK 1152470 A1 HK1152470 A1 HK 1152470A1
Authority
HK
Hong Kong
Prior art keywords
amyloidoses
peptides
treating beta
beta
treating
Prior art date
Application number
HK11106465.0A
Other languages
English (en)
Chinese (zh)
Inventor
Markus Mandler
Christian Gieffers
Frank Mattner
Andrea Dolischka
Oleksandr Otava
Original Assignee
Affiris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affiris Ag filed Critical Affiris Ag
Publication of HK1152470A1 publication Critical patent/HK1152470A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11106465.0A 2008-06-12 2011-06-22 Peptides for treating beta amyloidoses HK1152470A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0095108A AT506819B1 (de) 2008-06-12 2008-06-12 Vakzin zur behandlung von alzheimer-krankheit
PCT/AT2009/000236 WO2009149486A2 (en) 2008-06-12 2009-06-12 Compounds for treating diseases

Publications (1)

Publication Number Publication Date
HK1152470A1 true HK1152470A1 (en) 2012-03-02

Family

ID=41401982

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11106465.0A HK1152470A1 (en) 2008-06-12 2011-06-22 Peptides for treating beta amyloidoses

Country Status (22)

Country Link
US (2) US8613931B2 (de)
EP (1) EP2310034B9 (de)
JP (2) JP2011522841A (de)
KR (1) KR20110036808A (de)
CN (1) CN102123727B (de)
AT (3) AT506819B1 (de)
AU (1) AU2009257169B2 (de)
BR (1) BRPI0915137A2 (de)
CA (1) CA2723991A1 (de)
CY (1) CY1115316T1 (de)
DK (1) DK2310034T3 (de)
ES (1) ES2461492T3 (de)
HK (1) HK1152470A1 (de)
HR (1) HRP20140586T1 (de)
IL (1) IL209895A (de)
MX (1) MX2010013648A (de)
PL (1) PL2310034T3 (de)
PT (1) PT2310034E (de)
RS (1) RS53236B (de)
RU (1) RU2553345C2 (de)
SI (1) SI2310034T1 (de)
WO (1) WO2009149486A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2576617B1 (de) 2010-06-04 2016-04-27 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin MONOKLONALE ANTIKÖRPER, DIE AUF Aß-OLIGOMERE ZIELEN
US20120321694A1 (en) * 2010-10-27 2012-12-20 Daniel Larocque Compositions and uses
US9617302B2 (en) * 2011-06-14 2017-04-11 National Taiwan University Peptide compounds for inhibition of platelet aggregation
GB201113570D0 (en) 2011-08-05 2011-09-21 Glaxosmithkline Biolog Sa Vaccine
SI2579042T1 (sl) 2011-10-04 2014-09-30 Affiris Ag Postopek za detektiranje Ass-specifičnih protiteles v biološkem vzorcu
EP2659908A1 (de) 2012-05-01 2013-11-06 Affiris AG Zusammensetzungen
EP2787347A1 (de) 2013-04-03 2014-10-08 Affiris AG Verfahren zur Erkennung von Aß-spezifischen Antikörpern in einer biologischen Probe
FI3137094T3 (fi) 2014-04-29 2023-03-20 Advantage Therapeutics Inc Alzheimerin taudin (ad) hoitaminen ja ehkäiseminen
WO2015165961A1 (en) 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
WO2015165964A1 (en) * 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
WO2015175769A1 (en) 2014-05-15 2015-11-19 Biogen Ma Inc. Methods for the detection of amyloid beta oligomers in biological samples
KR20180088828A (ko) * 2015-11-09 2018-08-07 더 유니버시티 오브 브리티쉬 콜롬비아 아밀로이드 베타에서의 n-말단 에피토프 및 이에 형태적으로-선택적인 항체
JP7448174B2 (ja) * 2015-11-09 2024-03-12 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア アミロイドベータ中間領域エピトープおよびそれに対する立体配座選択的抗体
CN108350053A (zh) * 2015-11-09 2018-07-31 英属哥伦比亚大学 淀粉样蛋白β表位及其抗体
ES2571055B1 (es) * 2016-02-15 2016-12-28 Araclon Biotech, S.L. Conjugado amiloide y usos y procedimientos del mismo
MX2019000047A (es) * 2016-06-29 2019-07-04 Univ California Inhibidores peptídicos de la acumulación de alfa-sinucleína basados en estructuras.
US20180125920A1 (en) 2016-11-09 2018-05-10 The University Of British Columbia Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
CN109985231A (zh) * 2018-01-02 2019-07-09 上海清流生物医药科技有限公司 一种蛋白在制备预防和治疗痴呆症的药物中的应用
CA3192383A1 (en) * 2020-09-17 2022-03-24 Robin Barbour .beta.-amyloid vaccine for the treatment of alzheimer's disease
CN112608926A (zh) * 2020-12-08 2021-04-06 安徽大千生物工程有限公司 一种用于检测β淀粉样蛋白的基因序列组、杂交瘤细胞组及胶乳增强免疫比浊法试剂盒
CN113061161B (zh) * 2021-04-02 2023-09-12 河南省农业科学院动物免疫学重点实验室 靶向amyloid-beta结构的抑制性肽配基及应用
WO2023161526A1 (en) 2022-02-28 2023-08-31 Tridem Bioscience Gmbh & Co Kg A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
RU2294211C2 (ru) * 2001-01-19 2007-02-27 Цитос Байотекнолоджи Аг Композиция и способ для иммунизации, способ продуцирования неприродного, упорядоченного и повторяющегося массива антигенов
US20040265849A1 (en) * 2002-11-22 2004-12-30 Applera Corporation Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
AT413945B (de) 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
US7358331B2 (en) 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
WO2005023985A2 (en) * 2003-09-03 2005-03-17 University Of Rochester Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
US20050176030A1 (en) * 2003-10-28 2005-08-11 Li Gan Regulated nucleic acids in pathogenesis of Alzheimer's Disease
AT413946B (de) * 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
AT500483B1 (de) * 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
GB0421639D0 (en) 2004-09-29 2004-10-27 Proteome Sciences Plc Methods and compositions relating to alzheimer's disease
EP1812062B1 (de) 2004-10-25 2022-03-09 Merck Sharp & Dohme Corp. Anti-addl-antikörper und ihre verwendungen
EP2441469A1 (de) * 2006-03-14 2012-04-18 Oregon Health and Science University Verfahren zur Erzeugung einer Immunantwort auf Tuberculosis
WO2008002893A2 (en) 2006-06-29 2008-01-03 Centocor, Inc. Anti-amyloid antibodies, compositions, methods and uses
WO2009091518A2 (en) * 2008-01-15 2009-07-23 Monsanto Technology, Llc Isolated novel nucleic acid and protein molecules from corn and methods of using those molecules to generate transgenic plant with enhanced agronomic traits

Also Published As

Publication number Publication date
CA2723991A1 (en) 2009-12-17
US8613931B2 (en) 2013-12-24
AT509106B1 (de) 2011-12-15
ES2461492T3 (es) 2014-05-20
BRPI0915137A2 (pt) 2016-02-16
RU2011100126A (ru) 2012-07-20
JP6041917B2 (ja) 2016-12-14
US20130230545A1 (en) 2013-09-05
AT506819B1 (de) 2011-06-15
PT2310034E (pt) 2014-06-05
KR20110036808A (ko) 2011-04-11
DK2310034T3 (da) 2014-04-28
AT506819A1 (de) 2009-12-15
EP2310034A2 (de) 2011-04-20
RS53236B (en) 2014-08-29
CY1115316T1 (el) 2017-01-04
CN102123727B (zh) 2015-06-10
IL209895A (en) 2015-09-24
IL209895A0 (en) 2011-02-28
AU2009257169A1 (en) 2009-12-17
AU2009257169B2 (en) 2015-06-25
EP2310034B1 (de) 2014-03-26
JP2011522841A (ja) 2011-08-04
AT509105B1 (de) 2011-12-15
AT509106A1 (de) 2011-06-15
SI2310034T1 (sl) 2014-05-30
JP2015147771A (ja) 2015-08-20
EP2310034B9 (de) 2014-12-17
WO2009149486A2 (en) 2009-12-17
HRP20140586T1 (hr) 2014-09-12
WO2009149486A3 (en) 2010-06-10
CN102123727A (zh) 2011-07-13
PL2310034T3 (pl) 2014-08-29
MX2010013648A (es) 2011-04-05
AT509105A1 (de) 2011-06-15
RU2553345C2 (ru) 2015-06-10
US20110097351A1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
HK1152470A1 (en) Peptides for treating beta amyloidoses
IL209894A0 (en) Compounds for treating amyloidoses
EP2307035A4 (de) Behandlung von epilepsie
EP2123631A4 (de) Verfahren zur herstellung von alkoxypropionamid
GB0808973D0 (en) Radiotherapy apparatus
GB0820950D0 (en) Funnel
HK1177118A1 (en) Comb for treating pediculosis
GB0801209D0 (en) Process
ZA201204845B (en) Agents for treating disease
EP2348042A4 (de) Modifiziertes amyloid-beta-peptid
HK1154797A1 (en) Composition for treating disease
HK1155334A1 (en) Comb
GB0800875D0 (en) Process
EP2240177A4 (de) Behandlungen von nervenleiden
HK1220703A1 (zh) 改進的β胸腺素片段
GB0811851D0 (en) Process
EP2296461A4 (de) Verfahren zur behandlung von arthropoden
EP2340195A4 (de) Ständer
GB0908678D0 (en) Metering apparatus
GB0820166D0 (en) Former
GB0804759D0 (en) Shield
SI2341937T1 (sl) Sestavek za zdravljenje bolezni
AU323246S (en) Coffeemachine for coffeepods
GB0822652D0 (en) Shield
GB0806985D0 (en) Shield

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180612